KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Free Cash Flow (2016 - 2025)

Evolent Health has reported Free Cash Flow over the past 11 years, most recently at $41.0 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $41.0 million for Q4 2025, up 226.73% from a year ago — trailing twelve months through Dec 2025 was $4.8 million (up 177.59% YoY), and the annual figure for FY2025 was $4.8 million, up 177.59%.
  • Free Cash Flow for Q4 2025 was $41.0 million at Evolent Health, up from $6.8 million in the prior quarter.
  • Over the last five years, Free Cash Flow for EVH hit a ceiling of $83.3 million in Q4 2023 and a floor of -$66.0 million in Q1 2022.
  • Median Free Cash Flow over the past 5 years was $2.0 million (2022), compared with a mean of $3.8 million.
  • Biggest five-year swings in Free Cash Flow: soared 502.64% in 2023 and later crashed 820.09% in 2025.
  • Evolent Health's Free Cash Flow stood at $59.4 million in 2021, then crashed by 58.0% to $25.0 million in 2022, then surged by 233.96% to $83.3 million in 2023, then tumbled by 138.86% to -$32.4 million in 2024, then surged by 226.73% to $41.0 million in 2025.
  • The last three reported values for Free Cash Flow were $41.0 million (Q4 2025), $6.8 million (Q3 2025), and -$39.1 million (Q2 2025) per Business Quant data.